临床外科杂志 ›› 2026, Vol. 34 ›› Issue (9): 993-997.doi: 10.3969/j.issn.1005-6483.20250546

• 论著 • 上一篇    下一篇

血清白细胞介素-6、高迁移率族蛋白A2、维甲酸诱导基因6与分化型甲状腺癌病人临床病理特征及术后淋巴结转移的相关性

赵德江 杨二华 杨芝梦 郭天华   

  1. 673199 云南怒江,云南省怒江州人民医院普外烧伤科
  • 收稿日期:2025-05-26 出版日期:2026-09-20 发布日期:2026-09-20
  • 通讯作者: 赵德江,Email:boxe11@163.com
  • 基金资助:
    云南省科技厅科技计划项目(202201AZ070002-126)

Correlation between serum IL-6, HMGA2, STRA6 with clinical pathological features and postoperative lymph node metastasis in patients with differentiated thyroid cancer

ZHAO Dejiang,YANG Erhua,YANG Zhimeng,GUO Tianhua   

  1. Department of General Burn Surgery, Nujiang Prefecture People's Hospital, Nujiang 673199, China
  • Received:2025-05-26 Online:2026-09-20 Published:2026-09-20

摘要: 目的 探讨血清白细胞介素(IL)-6、高迁移率族蛋白A2(HMGA2)、维甲酸诱导基因6(STRA6)与分化型甲状腺癌(DTC)病人临床病理特征及术后淋巴结转移的关系。方法 2021年3月~2024年7月收治的84例DTC病人为DTC组,同期97例甲状腺良性疾病病人为良性组,根据术后6个月内淋巴结转移情况将DTC病人分为未转移组(60例)和转移组(24例)。酶联免疫吸附试验检测血清IL-6、HMGA2、STRA6。相关性分析采用Spearman法;受试者工作特征(ROC)曲线分析血清IL-6、HMGA2、STRA6对DTC病人术后淋巴结转移的预测效能。结果 DTC组和良性组血清IL-6分别为(188.47±31.14)pg/ml和(152.35±25.09)pg/ml,HMGA2分别为(11.23±2.25)ng/ml和(6.07±1.34)ng/ml,STRA6水平分别为(95.09±14.89)ng/ml和(65.16±10.28)ng/ml],两组比较差异有统计学意义(P<0.05)。Spearman分析结果 显示,血清IL-6、HMGA2、STRA6与DTC病人TNM分期存在相关性(P<0.05)。转移组与未转移组肿瘤最大径和TNM分期比较差异有统计学意义(P<0.05)。与未转移组比较,转移组术前及术后血清IL-6、HMGA2、STRA6水平均较高,差异有统计学意义(P<0.05)。ROC曲线分析显示,血清IL-6、HMGA2、STRA6联合预测DTC病人术后淋巴结转移的曲线下面积(AUC)(0.926)高于IL-6(Z=2.514,P=0.012)、HMGA2(Z=2.089,P=0.037)及STRA6(Z=2.008,P=0.045)单独预测。结论 DTC病人血清IL-6、HMGA2、STRA6水平较高,且与病人TNM分期有关,三者联合对DTC病人术后淋巴结转移具有较高预测价值。

关键词: 分化型甲状腺癌; 临床病理特征; 淋巴结转移; 白细胞介素-6; 高迁移率族蛋白A2; 维甲酸诱导基因6

Abstract: Objective To explore the relationship between serum interleukin-6 (IL-6), high mobility group protein A2 (HMGA2), stimulated by retinoic acid 6 (STRA6) with the clinical pathological features and postoperative lymph node metastasis of differentiated thyroid cancer (DTC) patients.Methods From March 2021 to July 2024, 84 DTC patients in our hospital were designated as the DTC group, and another 97 patients with benign thyroid diseases were designated as the benign group.The DTC patients was assigned into non metastatic group (n=60) and metastatic group (n=24) based on lymph node metastasis within 6 months after surgery.Enzyme-linked immunosorbent assay was used to detect serum IL-6, HMGA2, and STRA6.The correlation analysis was conducted using Spearman's method.Receiver operating characteristic (ROC) curve was used to explore the predictive efficacy of serum IL-6, HMGA2, and STRA6 for postoperative lymph node metastasis in DTC patients.Results Compared with the benign group, the levels of serum IL-6 [(188.47±31.14) vs (152.35±25.09) pg/ml], HMGA2 [(11.23±2.25) vs (6.07±1.34) ng/ml], and STRA6 [(95.09±14.89) vs (65.16±10.28) ng/ml] were higher in the DTC group (P < 0.05).Spearman analysis showed that serum IL-6, HMGA2, and STRA6 correlated with TNM staging in DTC patients (P<0.05).There was a statistically significant difference in the maximum tumor diameter and TNM stage between the metastasis group and the non-metastasis group (P<0.05).For the non metastatic group, the metastatic group had higher preoperative and postoperative serum IL-6, HMGA2, and STRA6 (P<0.05).ROC analysis showed that the joint of serum IL-6, HMGA2, and STRA6 had a higher area under the curve (AUC) (0.926) in predicting postoperative lymph node metastasis in DTC than the individual predictions of IL-6 (Z=2.514, P=0.012), HMGA2 (Z=2.089, P=0.037), and STRA6 (Z=2.008, P=0.045).Conclusion The levels of IL-6, HMGA2 and STRA6 in the serum of DTC patients are relatively high and are related to the TNM stage of the patients, and the combination of the three has a high predictive value for lymph node metastasis after surgery in DTC patients.

Key words: differentiated thyroid cancer; clinical pathological features; lymph node metastasis; interleukin-6; high mobility group protein A2; stimulated by retinoic acid 6

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[2] 胡光俊;宋晓阳;陶军. 右美托咪定添加到罗哌卡因中对腰丛坐骨神经阻滞及镇静的影响[J]. 临床外科杂志, 2016, 24(10): 796 .
[3] 陈海滨;吕松岑. 全膝关节置换术术中止血药物的应用策略[J]. 临床外科杂志, 2016, 24(10): 800 .
[4] 周观金;彭昊;陈森. 全膝关节置换治疗膝关节炎术后早期镇痛的研究进展[J]. 临床外科杂志, 2016, 24(10): 804 .
[5] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[6] 李晓辉;金太欣;邵永胜 . 升结肠回盲部肿瘤侵犯乙状结肠22例治疗体会[J]. 临床外科杂志, 2016, 24(11): 841 .
[7] 刘鑫;金慧芳;张硕;等. 尿激酶治疗结核性包裹性胸腔积液不同时间后手术治疗的疗效分析[J]. 临床外科杂志, 2016, 24(11): 859 .
[8] 孙金亚;陈伟;邓飞;等. 限制补液在胸外伤继发急性肺损伤或急性呼吸窘迫综合征治疗中的应用[J]. 临床外科杂志, 2016, 24(11): 862 .
[9] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[10] 严文波;潘伟华;武志祥;等. 新生儿先天性腹裂外科处理后转归[J]. 临床外科杂志, 2016, 24(11): 879 .